Polaryx Therapeutics, Inc. (PLYX)

2.26 +0.04 (+1.80%) USD  |  NASDAQ  |  Aug 07, 16:00
2.25 -0.01 (-0.44%) After-Hours: 19:59
More

Polaryx Therapeutics EV to Assets (Quarterly)

EV to Assets (Quarterly) Chart

View EV to Assets (Quarterly) for PLYX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Assets (Quarterly) Chart
Start Trial

Historical EV to Assets (Quarterly) Data

View and export this data back to 2026. Start Trial.
Date Value
March 31, 2026 --

Enterprise Value Ratios (EV) Definition

Enterprise Value/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.

Read full definition.

EV to Assets (Quarterly) Range, Past 5 Years

View EV to Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Assets (Quarterly) Benchmarks

View EV to Assets (Quarterly) Benchmarks
Start Trial
Cocrystal Pharma, Inc. Upgrade
CNBX Pharmaceuticals, Inc. Upgrade
GB Sciences, Inc. --
Arvinas, Inc. --
Fulcrum Therapeutics, Inc. Upgrade

EV to Assets (Quarterly) Related Metrics

EV to CFO Upgrade
EV to Free Cash Flow Upgrade
EV to Earnings Upgrade